3Henri R, Lijnen. Endothelium in Hemostasis and thrombosis[J], Prog Cardio Dis. 1997, 4:343.
4Murakami T, Komiyama Y, Masuda M, et al. Flow cytometric analysis of platelet activation markers C62 P and CD63 in patients with coronary artery disease[J]. Eur J Clin Invest, 1996, 26:996 - 1003.
5Michael J, Carey, George M, et al. Dissem inated Intravascular Coagulation: Clinical and Laboration Aspects[J]. AM J Hematol, 1998,11:56- 65.
7Gattorno M, Vignola S, Barbano G, et al.Differences in tumor necrosis factor-alpha soluble receptor serum concentrationsbetween patients with Henoch-Schonlein purpura and pediatric systemic lupuserythematosus: pathogenetic implications[J]. J Rheumatol,1998,25(2):361.
8Jin DK, Kohsaka T, Jun A, et al. Complement 4 gene deletion in patients with IgA nephropathy and Henoch-Schonlein nephritis[J]. Child Nephrol Urol,1992,12:208.
9Amoroso A, Berrino M, Canale L, et al.Immunogenetics of Henoch-Schoenlein disease[J]. Eur J Immunogenet,1997,24:323.
10Liu ZH, Cheng ZH, Yu YS, et al. Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schonlein nephritis and IgA nephropathy[J].Kidney Int,1997, 51:1938.
